Veritas Pharma Stock Price Prediction
| VRTHF Stock | USD 0 0.00 0.00% |
Oversold Vs Overbought
0
Oversold | Overbought |
Using Veritas Pharma hype-based prediction, you can estimate the value of Veritas Pharma from the perspective of Veritas Pharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Veritas Pharma to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Veritas because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Veritas Pharma after-hype prediction price | USD 0.0015 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Veritas |
Veritas Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Veritas Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Veritas Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Veritas Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Veritas Pharma Estimiated After-Hype Price Volatility
In the context of predicting Veritas Pharma's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Veritas Pharma's historical news coverage. Veritas Pharma's after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Veritas Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Veritas Pharma is very steady at this time. Analysis and calculation of next after-hype price of Veritas Pharma is based on 3 months time horizon.
Veritas Pharma Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Veritas Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Veritas Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Veritas Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Any time |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0 | 0 | 0.00 |
|
Veritas Pharma Hype Timeline
Veritas Pharma is at this time traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Veritas is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Veritas Pharma is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 27.0% of the company outstanding shares are owned by insiders. The company has Price to Book (P/B) ratio of 0.43. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Veritas Pharma recorded a loss per share of 0.03. The entity last dividend was issued on the 11th of February 2019. The firm had 1:2 split on the 10th of December 2021. Assuming the 90 days horizon the next forecasted press release will be any time. Check out Veritas Pharma Basic Forecasting Models to cross-verify your projections.Veritas Pharma Related Hype Analysis
Having access to credible news sources related to Veritas Pharma's direct competition is more important than ever and may enhance your ability to predict Veritas Pharma's future price movements. Getting to know how Veritas Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Veritas Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GRCU | Green Cures Botanical | 0.00 | 0 per month | 26.22 | 0.23 | 100.00 | (50.00) | 150.00 | |
| GXXY | Galexxy Holdings | 0.00 | 0 per month | 0.00 | (0.03) | 12.97 | (18.69) | 67.08 | |
| INQD | Indoor Harvest Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SPBBF | Speakeasy Cannabis Club | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BHHKF | Benchmark Botanics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LRSV | Link Reservations | 0.00 | 0 per month | 0.00 | 0.04 | 0.00 | (28.57) | 150.00 |
Veritas Pharma Additional Predictive Modules
Most predictive techniques to examine Veritas price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Veritas using various technical indicators. When you analyze Veritas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Veritas Pharma Predictive Indicators
The successful prediction of Veritas Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Veritas Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Veritas Pharma based on analysis of Veritas Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Veritas Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Veritas Pharma's related companies.
Story Coverage note for Veritas Pharma
The number of cover stories for Veritas Pharma depends on current market conditions and Veritas Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Veritas Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Veritas Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Veritas Pharma Short Properties
Veritas Pharma's future price predictability will typically decrease when Veritas Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Veritas Pharma often depends not only on the future outlook of the potential Veritas Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Veritas Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Float | 62.5 M |
Complementary Tools for Veritas Pink Sheet analysis
When running Veritas Pharma's price analysis, check to measure Veritas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veritas Pharma is operating at the current time. Most of Veritas Pharma's value examination focuses on studying past and present price action to predict the probability of Veritas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veritas Pharma's price. Additionally, you may evaluate how the addition of Veritas Pharma to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |